Responsive image

Mark Your Calendar!
October 7-9, 2021

Responsive image

Advancing Care Through Genomics

Virtual Speaker Series

The impact of genomics and individualized medicine on clinical practice evolves daily. Stay ahead of the emerging research and update your practice by tuning into a session of the Advancing Care Through Genomics Virtual Speaker Series.

 


Viruses for Cancer Therapy: A Promising Treatment in Need of a Personalized Approach
August 25, 1:00 PM CDT
Stephen Russell, MD, PhD

The fight against cancer includes the amazing microscopic invaders, oncolytic viruses. A foe of cancer cells, oncolytic viruses can make a difference in the war on cancer through a personalized approach. Join Stephen J. Russell, M.D., Ph.D., as he discusses the value of oncolytic virotherapy in treating cancer.

 


Exposomics: 2020 and Beyond
September 11, 12:00 PM CDT
Gary Miller, Ph.D. & Konstantinos Lazaridis, M.D., Ph.D.

Ponder the measure of all exposures of an individual during a lifetime, and the interactions with the individual’s genome. When genetics alone cannot explain a disease, we enter the world of exposomes. Join Gary W. Miller, Ph.D., and Konstantinos N. Lazaridis, M.D., Ph.D., as they discuss the current and future state of how environmental exposures we face impact health.

 


"Beyond DNA" in Cancer and Obesity
September 15, 12:00 PM CDT
Marina R. Walther-Antonio, Ph.D & Andres J. Acosta, M.D., Ph.D.

In our world’s fight against cancer and obesity, we need more than a “one-size-fits-all” solution. The development of individualized treatments is critical to the success for those who suffer from cancer and obesity. Join Marina R. Walther-Antonio, Ph.D., and Andres J. Acosta, M.D., Ph.D., as they discuss the role of precision medicine in cancer and obesity.

 


Precision Patient Care Using Genomics, Technology and Artificial Intelligence (AI)
October 1, 4:00 PM CDT
Bradley J. Erickson, M.D., Ph.D., Arjun P. Athreya, Ph.D., M.S., & John Kalantari, Ph.D.

Artificial Intelligence (AI), can individualize medical care well beyond what genomics alone can do. Developments in AI will allow us to move from a reactive and corrective treatment paradigm to one that is preventative, personalized and curative. Join Bradley J. Erickson, M.D., Ph.D., Arjun P. Athreya, Ph.D., M.S., and John Kalantari, Ph.D., as they discuss the role of technology and artificial intelligence in driving therapeutic options for patients.

If you have additional registration questions, email imconference@mayo.edu.